Current relevance of fungal and trypanosomatid glycolipids and sphingolipids: studies defining structures conspicuously absent in mammals.
Recently, glycosphingolipids have been attracting attention due to their role on biological systems as second messengers or modulators of signal transduction, affecting several events, which range from apoptosis to regulation of the cell cycle. In pathogenic fungi, glycolipids are expressed in two classes: neutral monohexosylceramides (glucosyl-or galactosylceramide) and acidic glycosylinositol phosphorylceramides (the latter class carries longer glycan chains). It is worth to mention that monohexosylceramides exhibit significant structural differences in their lipid moieties compared to their mammalian counterparts, whereas the glycosylinositol phosphorylceramides exhibit remarkable structural differences in their carbohydrate moieties in comparison to mammal glycosphingolipids counterpart. We observed that glycosylinositol phosphorylceramides are capable of promoting immune response in infected humans. In addition, inhibiting fungal glycosphingolipid biosynthetic pathways leads to an inhibition of colony formation, spore germination, cell cycle, dimorphism and hyphal growth. Other pathogens, such as trypanosomatids, also present unique glycolipids, which may have an important role for the parasite development and/or disease establishment. Regarding host-pathogen interaction, cell membrane rafts, which are enriched in sphingolipids and sterols, participate in parasite/fungal infection. In this review, it is discussed the different biological roles of (glyco) (sphingo)lipids of pathogenic/opportunistic fungi and trypanosomatids.
Takahashi
Helio K
HK
Setor de Imunoquímica de Glicoconjugados, Departamento de Bioquímica, Ed. J.L. Prado, Rua Botucatu, 862, 04023-900 São Paulo, SP, Brasil.
Toledo
Marcos S
MS
Suzuki
Erika
E
Tagliari
Loriane
L
Straus
Anita H
AH
D000818:Animals; D005658:Fungi / Q000737:chemistry* / Q000502:physiology; D006017:Glycolipids / Q000502:physiology*; D017261:Glycosylphosphatidylinositols / Q000502:physiology; D054884:Host-Pathogen Interactions / Q000502:physiology; D006801:Humans; D007891:Leishmania / Q000737:chemistry* / Q000502:physiology; D008565:Membrane Proteins / Q000502:physiology; D013107:Sphingolipids / Q000502:physiology*
D006017:Glycolipids; D017261:Glycosylphosphatidylinositols; D008565:Membrane Proteins; D013107:Sphingolipids